VESIX
Live / Applied — First extension granted (statement of use) (as of 24 Sept 2025)
What this means for you
Not registered yet, but its 23 Jul 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98662597
- Mark type
- Stylized text
- Filed
- 23 Jul 2024
- Published for opposition
- 04 Feb 2025
- Attorney of record
- Christopher R. Butler
Goods and services
- Class 005 — Pharmaceuticals: Antibacterial pharmaceuticals; Pharmaceutical preparations for the treatment and prevention of recurrent bacterial infections; Pharmaceutical preparations for the treatment of recurrent bacterial infections; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for use in urology; Pharmaceuticals, namely, anti-infectives
Owner
- US BioPharma LLC, Punta Gorda, FL, US
- US BioPharma LLC, Punta Gorda, FL, US
Prosecution history
- 25 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Sept 2025 — SOU EXTENSION 1 GRANTED
- 24 Sept 2025 — SOU EXTENSION 1 FILED
- 24 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Apr 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 04 Feb 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Feb 2025 — PUBLISHED FOR OPPOSITION
- 29 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Jan 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Jan 2025 — ASSIGNED TO EXAMINER
- 23 Jul 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 23 Jul 2024 — NEW APPLICATION ENTERED